Your session is about to expire
← Back to Search
Device
Multi-Speed Ergonomic Wheelchair for Spinal Cord Injury
N/A
Recruiting
Led By John M Looft, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 weeks after enrollment
Awards & highlights
No Placebo-Only Group
Summary
This trial will study a new wheelchair design to reduce shoulder pain for manual wheelchair users and improve their independence. #wheelchair #pain #independence
Who is the study for?
This trial is for individuals over 18 who use a manual wheelchair daily, weigh less than 125 kg, and can fit into wheelchairs with seat widths of 16" or 18". Participants must be able to make decisions and follow study procedures. Those with recent surgeries, pressure injuries, cardiovascular or pulmonary diseases that could affect safety are excluded.
What is being tested?
The study compares two types of ergonomic wheelchairs: one with multiple gear options versus a single-speed version. It aims to see if the multi-gear design improves hand rim positioning and reduces shoulder pain by offering easier movement initiation and adaptability to different terrains.
What are the potential side effects?
While not explicitly stated, potential side effects may include muscle strain or discomfort due to adapting to new wheelchair mechanics. However, the goal is to reduce shoulder pain and improve ergonomics.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 4 weeks after enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 weeks after enrollment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
20 Meter Push Test - Carpet, Gear Ratio 1:1
20 Meter Push Test - Carpet, Gear Ratio 2:3
20 Meter Push Test - Carpet, Gear Ratio 3:2
+26 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Multispeed Testing - Standard WheelchairExperimental Treatment1 Intervention
The second aim will have participants compared to the participant's standard wheelchair to a multi-speed (2 gear ratios) ergonomic wheelchair.
Group II: Multispeed Testing - Ergonomic WheelchairExperimental Treatment1 Intervention
The second aim will have participants compared to the participant's standard wheelchair to a multi-speed (2 gear ratios) ergonomic wheelchair.
Group III: Ergonomic Wheelchair Gear TestingExperimental Treatment1 Intervention
This study has two aims. The first aim will have participants use a single speed ergonomic wheelchair to test three different gear ratio set ups (3:2, 1:1, 2:3).
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,666 Previous Clinical Trials
3,765,779 Total Patients Enrolled
John M Looft, PhDPrincipal InvestigatorMinneapolis VA Health Care System, Minneapolis, MN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I understand and can decide to participate in this study.I can't get a suitable seat for the study's wheelchair.I cannot move a manual wheelchair by myself.I can fit into a wheelchair with a seat width of 16" or 18".I had surgery for a pressure sore less than a year ago.I use a manual wheelchair every day.
Research Study Groups:
This trial has the following groups:- Group 1: Ergonomic Wheelchair Gear Testing
- Group 2: Multispeed Testing - Ergonomic Wheelchair
- Group 3: Multispeed Testing - Standard Wheelchair
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.